‘Way too many people worry too much about big cars and fancy houses’ – Cathal Friel
Cathal Friel’s latest venture, Poolbeg Pharma, a clinical-stage infectious disease firm spun out of Open Orphan, aims to tap into the almost €200 billion infectious disease market